Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Objectives and Data Collection
2.3. Surgical Techniques
2.4. Statistical Analyses
3. Results
3.1. Preoperative Demographics and Surgical Procedures
3.2. Comparisons of Postoperative Outcomes Between 25G and 27G Groups
3.3. Primary Success Rates and Risk Factors for Surgical Failure
3.4. Surgical Failures and Complications
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. Ophthalmology 1988, 95, 1321–1334. [Google Scholar] [CrossRef]
- Berrocal, M.H.; Acaba, L.A.; Acaba, A. Surgery for Diabetic Eye Complications. Curr. Diabetes Rep. 2016, 16, 99. [Google Scholar] [CrossRef]
- Zhao, L.Q.; Zhu, H.; Zhao, P.Q.; Hu, Y.Q. A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy. Br. J. Ophthalmol. 2011, 95, 1216–1222. [Google Scholar] [CrossRef]
- Khan, M.A.; Shahlaee, A.; Toussaint, B.; Hsu, J.; Sivalingam, A.; Dugel, P.U.; Lakhanpal, R.R.; Riemann, C.D.; Berrocal, M.H.; Regillo, C.D.; et al. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease. Am. J. Ophthalmol. 2016, 161, 36–43.e2. [Google Scholar] [CrossRef]
- Yokota, R.; Inoue, M.; Itoh, Y.; Rii, T.; Hirota, K.; Hirakata, A. Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy. Jpn. J. Ophthalmol. 2015, 59, 288–294. [Google Scholar] [CrossRef]
- Sano, M.; Inoue, M.; Itoh, Y.; Hirota, K.; Koto, T.; Hirakata, A. Efficacy of higher cutting rates during microincision vitrectomy for proliferative diabetic retinopathy. Eur. J. Ophthalmol. 2016, 26, 364–368. [Google Scholar] [CrossRef]
- Oshima, Y.; Wakabayashi, T.; Sato, T.; Ohji, M.; Tano, Y. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology 2010, 117, 93–102.e2. [Google Scholar] [CrossRef] [PubMed]
- Yoneda, K.; Morikawa, K.; Oshima, Y.; Kinoshita, S.; Sotozono, C.; Japan Microincision Vitrectomy Surgery Study Group. Surgical Outcomes of 27-Gauge Vitrectomy for a Consecutive Series of 163 Eyes with Various Vitreous Diseases. Retina 2017, 37, 2130–2137. [Google Scholar] [CrossRef]
- Benzerroug, M.; Marchand, M.; Coisy, S.; Briend, B.; Boussion, B.; Mazit, C. 25-Gauge Versus 27-Gauge Vitrectomy for Management of Vitreoretinal Diseases: A Large Prospective Randomized Trial. Retina 2024, 44, 991–996. [Google Scholar] [CrossRef]
- Liu, J.; Liu, B.; Liu, J.; Wen, D.; Wang, M.; Shao, Y.; Li, X. Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: A randomized controlled trial. BMC Ophthalmol. 2023, 23, 504. [Google Scholar] [CrossRef]
- Tekin, K.; Sonmez, K.; Inanc, M.; Ozdemir, K.; Goker, Y.S.; Yilmazbas, P. Evaluation of corneal topographic changes and surgically induced astigmatism after transconjunctival 27-gauge microincision vitrectomy surgery. Int. Ophthalmol. 2018, 38, 635–643. [Google Scholar] [CrossRef] [PubMed]
- Nishigushi, R.; Usui-Ouchi, A.; Sakanishi, Y.; Tamaki, K.; Mashimo, K.; Ito, R.; Sakuma, T.; Ebihara, N.; Nakao, S. Outcomes, efficacy and risk factors of 27-Gauge vitrectomy for diabetic tractional retinal detachment in Japanese patients. Jpn. J. Ophthalmol. 2025, 69, 59–65. [Google Scholar] [CrossRef]
- Huang, C.H.; Hsieh, Y.T.; Yang, C.M. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: Clinical features and surgical outcomes. Graefes Arch. Clin. Exp. Ophthalmol. 2017, 255, 863–871. [Google Scholar] [CrossRef]
- Chen, P.L.; Chen, Y.T.; Chen, S.N. Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy. PLoS ONE 2021, 16, e0249139. [Google Scholar] [CrossRef]
- Li, S.; Li, Y.; Wei, L.; Fang, F.; Jiang, Y.; Chen, K.; Yang, X.; Liu, H. 27-gauge microincision vitrectomy surgery compared with 25-gauge microincision vitrectomy surgery on wound closure and need for wound suture and other postoperative parameters in the treatment of vitreoretinal disease: A meta-analysis. Int. Wound J. 2023, 20, 740–750. [Google Scholar] [CrossRef] [PubMed]
- Naruse, Z.; Shimada, H.; Mori, R. Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy. Int. Ophthalmol. 2019, 39, 1973–1980. [Google Scholar] [CrossRef]
- Inoue, M.; Koto, T.; Hirakata, A. Flow dynamics of beveled-tip and flat-tip vitreous cutters. Retina 2021, 41, 445–453. [Google Scholar]
- Inoue, M.; Koto, T.; Hirakata, A. Comparisons of Flow Dynamics of Dual-Blade to Single-Blade Beveled-Tip Vitreous Cutters. Ophthalmic Res. 2022, 65, 216–228. [Google Scholar] [CrossRef]
- Farouk, M.M.; Naito, T.; Sayed, K.M.; Nagasawa, T.; Katome, T.; Radwan, G.; Abdallah, A.; Elagouz, M. Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249, 369–376. [Google Scholar] [CrossRef]
- Alshaikhsalama, A.M.; Thompson, K.N.; Patrick, H.; Lee, J.; Voor, T.A.; Wang, A.L. Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy. Ophthalmol. Retina 2024, 8, 823–831. [Google Scholar] [CrossRef]
- Storey, P.P.; Ter-Zakarian, A.; Philander, S.A.; Olmos de Koo, L.; George, M.; Humayun, M.S.; Rodger, D.C.; Ameri, H. Visual and Anatomical Outcomes after Diabetic Traction and Traction-Rhegmatogenous Retinal Detachment Repair. Retina 2018, 38, 1913–1919. [Google Scholar] [CrossRef] [PubMed]
- Hutton, W.L.; Bernstein, I.; Fuller, D. Diabetic traction retinal detachment. Factors influencing final visual acuity. Ophthalmology 1980, 87, 1071–1077. [Google Scholar] [CrossRef] [PubMed]
- Jackson, T.L.; Johnston, R.L.; Donachie, P.H.J.; Williamson, T.H.; Sparrow, J.M.; Steel, D.H. The Royal College of Ophthalmologists’ National Ophthalmology Database Study of Vitreoretinal Surgery: Report 6, Diabetic Vitrectomy. JAMA Ophthalmol. 2016, 134, 79–85. [Google Scholar] [CrossRef] [PubMed]
- Dervenis, P.; Dervenis, N.; Smith, J.M.; Steel, D.H.W. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy. Cochrane Database Syst. Rev. 2023, 2023, CD008214. [Google Scholar] [CrossRef]
Total (n = 83) | 25G (n = 25) | 27G (n = 58) | p Value | |
---|---|---|---|---|
Age (years) (median) (range) | 50.0 (27–75) | 51.0 (27–75) | 49.5 (31–69) | 0.636 § |
Male, n (%) | 63 (76%) | 19 (76%) | 44 (76%) | 0.989 † |
Type 1 diabetes mellitus, n (%) | 4 (5%) | 2 (8%) | 2 (3%) | 0.921 ‡ |
Preoperative BCVA (logMAR) (median) (range) | 1.0 (−0.08–4.0) | 1.3 (0.2–4.0) | 0.9 (−0.08–2.3) | 0.344 § |
IOP (mmHg) (median) (range) | 15.0 (8–36) | 13.0 (9–35) | 15.0 (8–36) | 0.542 § |
PDR grade, n (%) | 0.129 ‡ | |||
1 | 10 (12%) | 1 (4%) | 9 (16%) | |
2 | 35 (42%) | 8 (32%) | 27 (27%) | |
3 | 34 (41%) | 14 (56%) | 20 (35%) | |
4 | 4 (5%) | 2 (8%) | 2 (4%) | |
PDR type, n (%) | 0.010 *,‡ | |||
III | 39 (47%) | 7 (28%) | 32 (55%) | |
IV | 17 (21%) | 10 (40%) | 7 (12%) | |
V | 27 (33%) | 19 (33%) | 8 (32%) | |
Preoperative laser photocoagulation, n (%) | 72 (87%) | 19 (76%) | 53 (91%) | 0.027 *,† |
Neovascular glaucoma, n (%) | 3 (4%) | 2 (8%) | 1 (2%) | 0.183 † |
Macular detachment, n (%) | 31 (37%) | 15 (60%) | 16 (28%) | 0.006 *,† |
Preoperative anti-VEGF injection, n (%) | 14 (17%) | 4 (16%) | 10 (17%) | 0.889 † |
Preoperative ELM disruption, n (%) | 38 (60%) | 16 (73%) | 22 (54%) | 0.135 † |
Preoperative EZ disruption, n (%) | 47 (75%) | 18 (82%) | 29 (71%) | 0.900 † |
Preoperative DRIL, n (%) | 49 (78%) | 20 (91%) | 29 (71%) | 0.989 † |
Operation time (minutes) (median) (range) | 117.0 (38–284) | 111.0 (68–188) | 117.5 (38–284) | 0.976 § |
Iatrogenic break, n (%) | 53 (64%) | 16 (64%) | 37 (64%) | 0.986 † |
Perfluorocarbon liquid, n (%) | 28 (34%) | 9 (36%) | 19 (33%) | 0.775 † |
Bimanual technique, n (%) | 25 (30%) | 13 (52%) | 12 (21%) | 0.005 *,† |
Tamponade agent, n (%) | 64 (77%) | 21 (84%) | 43 (74%) | 0.315 † |
Re-Detachment (n = 5) | Primary Attachment (n = 78) | p Value | |
---|---|---|---|
Age (years) (median) (range) | 46.0 (41–74) | 50.5 (27–75) | 0.792 § |
Male, n (%) | 4 (80%) | 59 (75%) | 0.822 † |
Type 1 diabetes mellitus, n (%) | 1 (25%) | 4 (5%) | 0.224 ‡ |
Preoperative BCVA (logMAR) (median) (range) | 1.2 (0.5–1.7) | 0.9 (−0.08–4.0) | 0.826 § |
IOP mmHg (median) (range) | 10.0 (10–16) | 15.0 (8–36) | 0.085 § |
PDR grade, n (%) | 0.042 *,‡ | ||
1 | 0 (0%) | 10 (13%) | |
2 | 0 (0%) | 35 (45%) | |
3 | 4 (80%) | 30 (39%) | |
4 | 1 (20%) | 3 (4%) | |
PDR type, n (%) | 0.041 *,‡ | ||
III | 0 (0%) | 39 (50%) | |
IV | 2 (40%) | 15 (19%) | |
V | 3 (60%) | 24 (31%) | |
Preoperative laser photocoagulation, n (%) | 3 (60%) | 68 (87%) | 0.146 † |
Neovascular glaucoma, n (%) | 0 (0%) | 3 (4%) | 0.538 † |
Macular detachment, n (%) | 5 (46%) | 26 (31%) | 0.577 † |
Preoperative anti-VEGF injection, n (%) | 2 (40%) | 12 (15%) | 0.203 † |
Preoperative ELM disruption, n (%) | 5 (100%) | 33 (57%) | 0.071 ‡ |
Preoperative EZ disruption, n (%) | 5 (100%) | 42 (72%) | 0.218 ‡ |
Preoperative DRIL, n (%) | 5 (100%) | 44 (76%) | 0.271 ‡ |
Operation time (minutes) (median) (range) | 146.0 (96–188) | 116.5 (38–284) | 0.340 § |
25G, n (%) | 3 (12%) | 22 (88%) | 0.153 † |
Iatrogenic break, n (%) | 1 (20%) | 29 (37%) | 0.418 † |
Perfluorocarbon liquid, n (%) | 4 (80%) | 24 (31%) | 0.028 *,† |
Bimanual technique, n (%) | 4 (80%) | 21 (27%) | 0.017 *,† |
Tamponade agent, n (%) | 5 (100%) | 59 (76%) | 0.101 † |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ohara, H.; Torikai, T.; Takeuchi, J.; Yokoi, T.; Koto, T.; Inoue, M. Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy. J. Clin. Med. 2025, 14, 2533. https://doi.org/10.3390/jcm14072533
Ohara H, Torikai T, Takeuchi J, Yokoi T, Koto T, Inoue M. Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy. Journal of Clinical Medicine. 2025; 14(7):2533. https://doi.org/10.3390/jcm14072533
Chicago/Turabian StyleOhara, Hiromi, Tomohiko Torikai, Jun Takeuchi, Tadashi Yokoi, Takashi Koto, and Makoto Inoue. 2025. "Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy" Journal of Clinical Medicine 14, no. 7: 2533. https://doi.org/10.3390/jcm14072533
APA StyleOhara, H., Torikai, T., Takeuchi, J., Yokoi, T., Koto, T., & Inoue, M. (2025). Comparison of 27-Gauge to 25-Gauge Vitrectomy in Patients with Tractional Retinal Detachment Associated with Proliferative Diabetic Retinopathy. Journal of Clinical Medicine, 14(7), 2533. https://doi.org/10.3390/jcm14072533